The Coronavirus Vaccine Market is expected to grow at a -12.0 % CAGR during the forecast period for 2024-2034.
Coronavirus Disease (COVID-19) is caused by coronavirus. Coronavirus is a type of virus which causes respiratory illness in humans and can causes serious illness in geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). Out of the seven types of coronavirus, SARS-CoV-2 is the one which can cause severe diseases like Middle East respiratory syndrome (MERS) and sudden acute respiratory syndrome (SARS). Increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines, which will result in expansion of coronavirus vaccine market during the forecast period.
Major factors responsible for the growth of this market are fast adoption of advance technologies, growing number of corona patients, increasing healthcare expenditures, rising awareness about corona virus, and increasing efforts by the pharmaceutical companies for the development of covid-19 vaccines. Furthermore, increasing research investments for the R&D of covid-19 vaccines is anticipated to drive the market growth in future. However, high cost required for clinical trials and for validation of vaccines is restraining the growth of coronavirus vaccine market.
The Coronavirus Vaccine Market can be segmented on the basis of Infection Type, Vaccine Type, End-Users, and region. On the basis of Infection Type, the market can be divided into HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, and MERS-CoV. SARS-CoV segment is expected to dominate the market as this virus is the main reason of covid-19 outbreak. On the basis of Vaccine Type, the market can be segmented into Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, and S-Protein based coronavirus vaccine. In terms of End-Users, market is divided into Hospitals, Clinics, Research Institutes, and Others. On the basis of region, the market is segmented into the North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the coronavirus vaccine market in the coming future.
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of -25.0 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Infection Type, By Vaccine Type, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax, Inc, Moderna, AstraZeneca, Pfizer, Johnson &Johnson, GlaxoSmithKline, Bharath Biotech, Serum Institute of India, Sinopharm, AnGes, AIVITABiomedical, CanSinoBio, eubiologics, Genexine, GreenLight Bioscience, Gennova, Heat Biologics, INOVIO, IIBR, medicago, Symvivo, Valneva, Zydus Cadila, and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Coronavirus Vaccine Market Snapshot
Chapter 4. Global Coronavirus Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Clinical Trial/Pipeline Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Major Investment, Partnerships and Collaborations in COVID 19 Research
Chapter 5. Market Segmentation 1: By Infection Type, Estimates & Trend Analysis
5.1. By Infection Type, & Market Share, 2020 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Infection Type:
5.2.1. HCoV-229E
5.2.2. HCoV-OC43
5.2.3. SARS-CoV
5.2.4. New Haven CoV
5.2.5. HKU1-CoV
5.2.6. MERS-CoV
Chapter 6. Market Segmentation 2: By Vaccine Type Estimates & Trend Analysis
6.1. By Vaccine Type & Market Share, 2020 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Vaccine Type:
6.2.1. Protein subunit
6.2.2. Viral Vector (non-replicating)
6.2.3. DNA
6.2.4. Inactivated Virus
6.2.5. RNA
6.2.6. Viral Vector (replicating)
6.2.7. Virus Like Particle
6.2.8. Others
Chapter 7. Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2020& 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Research Institutes
7.2.4. Others
Chapter 8. Coronavirus Vaccine Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Infection Type, 2020-2030
8.1.2. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Vaccine Type, 2020-2030
8.1.3. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By End-Users, 2020-2030
8.1.4. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts by country, 2020-2030
8.2. Europe
8.2.1. Europe Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030
8.2.2. Europe Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030
8.2.3. Europe Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030
8.2.4. Europe Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030
8.3. Asia Pacific
8.3.1. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030
8.3.2. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030
8.3.3. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030
8.3.4. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030
8.4. Latin America
8.4.1. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)
8.4.2. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)
8.4.3. Latin America Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)
8.5.2. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)
8.5.3. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030
Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. I-Mab Biopharma
9.1.2. Medicago
9.1.3. Airway Therapeutics
9.1.4. Tiziana Life Sciences
9.1.5. Inovio Pharmaceuticals
9.1.6. Novavax, Inc
9.1.7. Moderna
9.1.8. AstraZeneca
9.1.9. Pfizer
9.1.10. Johnson &Johnson
9.1.11. GlaxoSmithKline
9.1.12. Bharath Biotech
9.1.13. Serum Institute of India
9.1.14. Sinopharm
9.1.15. AnGes
9.1.16. AIVITABiomedical
9.1.17. CanSinoBio
9.1.18. eubiologics
9.1.19. Genexine
9.1.20. GreenLight Bioscience
9.1.21. Gennova
9.1.22. Heat Biologics
9.1.23. INOVIO
9.1.24. IIBR
9.1.25. medicago
9.1.26. Symvivo
9.1.27. Valneva
9.1.28. Zydus Cadila
9.1.29. CODAGENIX Inc.
9.1.30. Other Prominent Player
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Infection Type
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Vaccine Type
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on End-Users
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region
North America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Europe coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Asia Pacific coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Latin America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Middle East & Africa coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Competitive Landscape